Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population

NCT05601167 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

264

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: nirmatrelvir/ritonavir
DRUG: Standard of care

Sponsor

Promomed, LLC

Collaborators

[object Object]